| Ytd | -39.88% | |
| 1y | 57.30% |
| Open | 2.80 | Prev Close | 2.69 | Low | 2.80 | High | 2.97 | Mkt Cap | 270.12M |
| Vol | 11.58K | Avg Vol | 31.85K | EPS | -0.67 | P/E | -4.01 | Forward P/E | -2.07 |
| Beta | 2.88 | Short Ratio | 1.41 | Inst. Own | 16.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.23 | 200-d Avg | 3.80 | 1yr Est | 6.67 |
CLLS News
EMERYVILLE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Prolynx, a biotechnology company developing a
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDA
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASD
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASD
PARIS, June 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Dat
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (Euronext Growth: ALCLS- NASDAQ
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDA
Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis
(Article 223-16 of General Regulation of the French financial markets authority) (Article 223-16 of
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NAS
NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Cellectis (or the “Company”) (Euronext Growth: ALCLS -
NEW YORK, 13 avr. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), société
U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt ro
(Article 223-16 of General Regulation of the French financial markets authority) (Article 223-16 of
Cellectis S.A. (CLLS) Q4 2025 Earnings Call Transcript
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NAS
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS, NASD
(Article 223-16 of General Regulation of the French financial markets authority) (Article 223-16 of
Shares of Cellectis S.A. (NASDAQ: CLLS - Get Free Report) passed below its 50 day moving average dur
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
During Monday's session, 402 companies made new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
On Friday, 209 companies set new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
Stocks That Hit 52-Week Lows On Monday
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018